Intuitive Surgical (NASDAQ:ISRG) Given New $621.00 Price Target at The Goldman Sachs Group

Intuitive Surgical (NASDAQ:ISRG) had its target price boosted by The Goldman Sachs Group from $609.00 to $621.00 in a research note released on Wednesday morning,MarketScreener reports. The brokerage currently has a buy rating on the medical equipment provider’s stock.

Several other research analysts have also issued reports on the stock. Argus dropped their price target on shares of Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating for the company in a research report on Wednesday, February 4th. UBS Group dropped their price target on shares of Intuitive Surgical from $570.00 to $550.00 and set a “neutral” rating for the company in a research report on Tuesday, March 17th. Raymond James Financial dropped their price target on shares of Intuitive Surgical from $615.00 to $577.00 and set an “outperform” rating for the company in a research report on Wednesday. TD Cowen dropped their price target on shares of Intuitive Surgical from $660.00 to $585.00 and set a “buy” rating for the company in a research report on Wednesday. Finally, Robert W. Baird dropped their price objective on shares of Intuitive Surgical from $645.00 to $575.00 and set an “outperform” rating for the company in a report on Wednesday, April 15th. Eighteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average price target of $586.70.

Intuitive Surgical Stock Up 7.2%

NASDAQ:ISRG opened at $483.62 on Wednesday. Intuitive Surgical has a 12-month low of $427.84 and a 12-month high of $603.88. The firm has a market capitalization of $171.75 billion, a PE ratio of 58.62, a price-to-earnings-growth ratio of 3.52 and a beta of 1.68. The firm has a 50-day moving average price of $477.54 and a 200 day moving average price of $515.41.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.96%. The firm had revenue of $2.77 billion during the quarter, compared to analyst estimates of $2.62 billion. During the same quarter in the prior year, the business posted $1.81 earnings per share. The company’s quarterly revenue was up 23.0% compared to the same quarter last year. On average, research analysts expect that Intuitive Surgical will post 8.16 EPS for the current year.

Insider Activity

In other news, SVP Patricia L. Wadors sold 220 shares of the firm’s stock in a transaction that occurred on Friday, February 27th. The shares were sold at an average price of $499.71, for a total transaction of $109,936.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Fredrik Widman sold 133 shares of the firm’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total transaction of $65,829.68. Following the sale, the vice president directly owned 660 shares of the company’s stock, valued at approximately $326,673.60. The trade was a 16.77% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 32,943 shares of company stock worth $17,279,568. Corporate insiders own 0.60% of the company’s stock.

Institutional Trading of Intuitive Surgical

Several hedge funds have recently modified their holdings of ISRG. Holos Integrated Wealth LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $25,000. Newbridge Financial Services Group Inc. increased its holdings in shares of Intuitive Surgical by 300.0% in the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 33 shares in the last quarter. Greykasell Wealth Strategies Inc. acquired a new stake in shares of Intuitive Surgical in the third quarter valued at approximately $27,000. Olistico Wealth LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $28,000. Finally, Caitlin John LLC acquired a new stake in shares of Intuitive Surgical in the third quarter valued at approximately $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Key Stories Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Q1 beat on top and bottom lines — Intuitive reported $2.50 non‑GAAP EPS vs. ~$2.08 expected and $2.77B revenue (≈23% YoY), which drove the immediate market rally. ISRG Stock Up as Q1 Earnings & Sales Beat Estimates on Procedure Growth
• Positive Sentiment: Procedure growth is the operational driver — combined da Vinci and Ion procedures grew meaningfully (da Vinci ≈16% and Ion ≈39% in Q1), supporting recurring consumables and service revenue. Intuitive Announces First Quarter Earnings
• Positive Sentiment: Company raised full‑year/procedure guidance — management modestly lifted its procedure-growth outlook for 2026, which investors read as validation that demand is holding. Intuitive Surgical Jumps 7% on Earnings Beat and Raised Full-Year Outlook
• Neutral Sentiment: Analyst reactions are mixed but active — several firms raised targets or reiterated Buys (Goldman, Baird), while others trimmed targets; net impact is more analyst attention and updated model assumptions. Analysts Boost Forecasts After Upbeat Q1
• Neutral Sentiment: Market volatility around the print — shares initially moved in after‑hours trading and then again on the next session as investors parsed the beat vs. the tone of guidance. Reuters: Intuitive Beats Quarterly Expectations
• Negative Sentiment: Guidance viewed as conservative by some — a few investors and writers note the raise was smaller than the quarter’s beat, and management flagged international headwinds; that tempers expectations for sustained upside. Why Robotics Giant Intuitive Surgical Dropped Despite Its Beat And Raise

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.